TABLE 1.
Post‐COVID‐19 syndrome clinical‐immunological predictive index (FANSY POSTCOV)
| OR | 95% CI | p‐value | Cut‐off point | Score | |
|---|---|---|---|---|---|
| Sex | 2.73 | 1.12 to 7.09 | 0.03 | Female | 5 |
| Number of symptoms at COVID‐19 diagnosis | 1.35 | 1.06 to 1.77 | 0.012 | >3.5 | 4 |
| CD24+CD38lo/‐ B cells | 1.13 | 1.02 to 1.25 | 0.03 | >2.805 | 3 |
| Naive CD4+ T cells | 0.93 | 0.87 to 0.99 | 0.009 | <9.58 | 2 |
| MFI of CD57 in CD8+ T cells | 1.00 | 1.00 to 1.00 | 0.04 | >22,785.5 | 1 |
Note: All features were evaluated at baseline (at hospital admission).
Abbreviations: COVID‐19, coronavirus disease 2019; CI, confidence interval; FANSY POSTCOV, Female, percentage of CD24+CD38–/lo (Atypical memory B cells), Naïve CD4+ T cells, expression of the Senescence marker CD57 in CD8+ T cells and the number of SYmptoms at COVID‐19 diagnosis; MFI, mean fluorescence intensity; OR, odds ratio.